Our findings have highlighted the challenges facing opioid treatment providers in prison in addressing patient ambivalence towards OST and preferences to cease OST prior to release, and can inform the development of policies and clinical practices that are mindful of patient perspectives and concerns (NDARC)
Bibliography: Interventions – Treatment
Emerging consensus on measuring addiction recovery
Findings from a multi-stakeholder consultation exercise (Drugs: Education, Prevention and Policy)
Emergency department-based brief interventions for individuals with substance-related problems: a review of effectiveness
This paper considers five systematic reviews and 16 randomised controlled trials and points to the potential benefits of brief interventions, albeit with a need for more research (EMCDDA
The extent and nature of addiction to medicines in Cheshire and Merseyside
The aim of this study was, therefore, twofold: (1) to investigate health professionals’ experiences of ATM and (2) their understanding of optimally identifying and addressing ATM (CPH)
How can opioid substitution therapy be optimised to maximise recovery outcomes for service users?
The second and concluding report on opioid substitution therapy from the Advisory Council on the Misuse of Drugs (ACMD)
Wales – Substance misuse statistics
These reports include statistics from the Welsh National Database for Substance Misuse and additional substance misuse related information available from routinely published sources in Wales (Welsh Government)
HIV and young people who inject drugs
Technical brief (WHO)
Factors affecting repeated cessations of injecting drug use and relapses during the entire injecting career among the Edinburgh Addiction Cohort
OST was associated with reduced time to cessation, and there was some suggestion of increased time to relapse too. The likelihood of prolonged cessation is greater for women, increases with age, and decreases with time since last relapse (Drug and Alcohol Dependence)
Drug-Related Hospital Statistics Scotland
This publication reports on hospital stays in relation to a drug misuse diagnosis and the patients admitted to hospital for such treatment (ISD)
PHE announces new capital funding for drug and alcohol recovery services
Public Health England has today announced the availability of £10 million of capital funding for services that are helping people in England with drug or alcohol problems to recover from their addiction
Naloxone – what the new legislation changes mean
Kate Halliday, SMMGP Programme Lead, discusses the recent legislation changes which make naloxone more readily available for those that need it (SMMGP)
New NDARC resource provides heroin dependence treatment information
A new information kit developed by researchers at the National Drug and Alcohol Research Centre at UNSW provides a step by step guide to the evidence for medically assisted treatment for heroin dependence as well as answering commonly asked questions (NDARC )
Drug misuse and dependence: UK guidelines on clinical management
Feedback received (Public Health England)
Medications to treat opioid use disorders
New guideline from the American Society of Addiction Medicine (EurekAlert)
David Best: Why the UK lags behind in recovery for drug users
It’s rare that you’ll see Blackpool praised by a professor of criminology, but when it comes to leading the way in changing how the powers that be handle recovery from substance abuse and dependency, it is certainly a shining example of success
Homelessness: an unhealthy state
Mental health issues were very common, with over half reporting a diagnosis of depression. Almost half of the sample had both a mental health problem and an addiction problem (Partnership for Health Equality, Ireland)
Recovery
Phoenix launches new report describing how communities can work together to provide friendly environments for people in recovery
Joint Strategic Needs Assessment resources for alcohol, drugs and tobacco
PHE has published the latest alcohol, drugs and tobacco joint strategic needs (JSNA) resource pack to help local areas develop joint strategic needs assessments and local joint health and wellbeing strategies that effectively address public health issues relating to alcohol, drug and tobacco use
Best practice in drug interventions
Discover what works (and what doesn’t work) in the areas of drug prevention, treatment, harm reduction and social reintegration (EMCDDA)
Turning evidence into practice: Preventing blood-borne viruses
This briefing aims to support local authorities and drug treatment and healthcare services to review their BBV prevention and treatment interventions for people who inject drugs (Public Health England)
- « Previous Page
- 1
- …
- 12
- 13
- 14
- 15
- 16
- 17
- Next Page »
